)] = 1.01 shares/ 1 warrant Where Price 1 = Exercise Price after the change Price 0 = Exercise Price prior the change Ratio 1 = Exercise Ratio after the change Ratio 0 = Exercise Ratio prior the change MP
Q3/16 Q2/17 Q3/17 Change +/(-) 9M/16 9M/17 Change +/(-) (Unit: THB million) QoQ YoY 9M Operating revenue 5,176 5,459 4,243 (22%) (18%) 16,214 15,067 (7%) Gross profit 1,046 1,256 1,199 (5%) 15% 3,485
the information memorandum which was previously disclosed to the Stock Exchange of Thailand. In this regard, the said asset disposal transactions do not constitute a connected transaction and the
Production and Installation machine business. 2. Eureka Design International Pte,.Ltd. (Singapore) , Investment in overseas business. This disposition is considered as the assets disposition transaction of
and Installation machine business. 2. Eureka Design International Pte,.Ltd. (Singapore) , Investment in overseas business. This disposition is considered as the assets disposition transaction of listed
www.interpharma.co.th IP_OCS/011/2020 8th June 2020 Subject: Notify the Resolutions of the Board of Directors Meeting, Change of Objectives of Funds Usage, Acquisition of Assets, The Issuance of Debentures and Fix the
three-month period ended Q1-2020 Q1-2019 Change 2020 2019 THB Mn % Sales of electricity - FiT 623.1 580.4 42.7 7.4 FiT Premium 43.7 42.6 1.1 2.6 Sales of electricity to Industrial Users (IU) 4.7 2.4 2.3